GlassScriptPhysician profile
Michael A Nicholas
NPI 1598740748
$22,481.60
in general payments reported to CMS, 2019-2025
32 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,066 · 2020: $816 · 2021: $1,208 · 2022: $4,613 · 2023: $6,430 · 2024: $4,179 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,660 · Food and Beverage: $5,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,660.01 |
| Food and Beverage | $5,117.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,685.02 | 2019-2024 | Watchman Access System, Ranger, Eluvia |
| W. L. Gore & Associates, INC. | $3,485.20 | 2022-2024 | Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis |
| Penumbra, INC. | $2,848.42 | 2019-2024 | Penumbra System, Indigo System, Ruby Coil |
| Medtronic, INC. | $1,760.77 | 2021-2025 | Cobalt Dr Mri Surescan, In.Pact Admiral, Micra |
| Abbott Laboratories | $1,657.53 | 2019-2024 | Acculink, Xact, Diamondback Peripheral |
| Medtronic Vascular, INC. | $1,632.15 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,030.62 | 2019-2024 | |
| Philips North America LLC | $1,024.21 | 2019-2024 | (6346) Intrasight Mobile |
| Abiomed | $959.85 | 2020-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $566.90 | 2019-2024 | Lifevest |
| Cardiovascular Systems INC. | $536.42 | 2019-2023 | Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $491.42 | 2019 | |
| Biotronik INC. | $432.94 | 2022-2024 | Orsiro Mission, Recross, Nhancer Rx |
| Inari Medical, INC. | $407.16 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $334.45 | 2019-2024 | Repatha |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $302.41 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.97 | 2019-2024 | Jardiance |
| Bard Peripheral Vascular, INC. | $222.42 | 2021-2022 | |
| Chiesi USA, INC. | $219.68 | 2020-2023 | Kengreal, Cleviprex |
| Pfizer INC. | $148.48 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $113.54 | 2023-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $109.67 | 2021 | |
| Esperion Therapeutics, INC. | $95.25 | 2021 | |
| Livanova USA, INC. | $28.96 | 2023 | Lifesparc |
| Veryan Medical Incorporated | $27.18 | 2023 | Biomimics 3d Vascular Stent System |
| Actelion Pharmaceuticals US, INC. | $22.75 | 2019 | |
| Cook Medical LLC | $18.46 | 2024 | Zilver Ptx |
| Sanofi-Aventis U.S. LLC | $18.17 | 2019 | |
| Angiodynamics, INC. | $17.31 | 2024 | Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $13.44 | 2024 | Hemosphere |
| Amarin Pharma, INC. | $13.04 | 2019 | |
| Gilead Sciences, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nicholas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.